Suchergebnisse - "Challener, Douglas W"

PubPharm (41)

11

Leptotrichia Bacteremia : 10-Year Retrospective Clinical Analysis and Antimicrobial Susceptibility Profiles

enthalten in: Journal of clinical microbiology | 2023

von Ranganath, N. | Shirley, J. | Challener, D. | +6

12

Rebound Phenomenon After Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease 2019 (COVID-19) in High-Risk Persons

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Ranganath, N. | O'Horo, J. | Challener, D. | +5

13

Risk factors and prophylaxis for nocardiosis in solid organ transplant recipients : A nested case‐control study

enthalten in: Clinical Transplantation | 2023

von Yetmar, Z. | Chesdachai, S. | Duffy, D. | +5

14

1,3-β-D-glucan testing for nocardiosis in solid organ transplant recipients

enthalten in: Transplant infectious disease : an official journal of the Transplantation Society | 2022

von Yetmar, Z. | Challener, D. | Seville, M. | +3

15

Curbing the Delta Surge : Clinical Outcomes After Treatment With Bamlanivimab-Etesevimab, Casirivimab-Imdevimab, or Sotrovimab for Mild to Moderate Coronavirus Disease 2019

enthalten in: Mayo Clinic proceedings | 2022

von Razonable, R. | O'Horo, J. | Challener, D. | +13

16

Utility of Follow-up Coronavirus Disease 2019 (COVID-19) Antigen Tests After Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Healthcare Personnel

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Tande, A. | Swift, M. | Challener, D. | +5

17

Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 2019

enthalten in: Mayo Clinic proceedings | 2022

von O'Horo, J. | Challener, D. | Anderson, R. | +8

18

Contemporary experience of Abiotrophia, Granulicatella and Gemella bacteremia

enthalten in: The Journal of infection | 2022

von Chesdachai, S. | Yetmar, Z. | Tabaja, H. | +5

19

Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant

enthalten in: Mayo Clinic proceedings | 2022

von O'Horo, J. | Challener, D. | Speicher, L. | +10

20

1,3‐β‐D‐glucan testing for nocardiosis in solid organ transplant recipients

enthalten in: Transplant Infectious Disease | 2022

von Yetmar, Z. | Challener, D. | Seville, M. | +3